Brian Adams, Chief Legal Officer at Relay Therapeutics, Inc. ($RLAY), made five open market sales of company shares over the past year, totaling $118 thousand. His latest sale occurred on July 29, 2025. These transactions rank 9,328th among 11,678 insiders in our database, well below the average sale value of 8.6 million across 6.4 transactions per insider on average. Adams recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Adams Brian | Chief Legal Officer | A | Common Stock | 4125 | $0.00 | 56,625.0000 | 87,300,286 | 7.86% | 0.00% |
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Adams Brian | Chief Legal Officer | A | Stock Option (Right to Buy) | 8250 | $0.00 | 8,250.0000 | 87,300,286 | 9999.99% | 0.01% |
| Sept. 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Adams Brian | Chief Legal Officer | A | Common Stock | 52500 | $0.00 | 52,500.0000 | 75,043,991 | 9999.99% | 0.07% |
| Sept. 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Adams Brian | Chief Legal Officer | A | Stock Option (Right to Buy) | 105000 | $0.00 | 105,000.0000 | 75,043,991 | 9999.99% | 0.14% |
| July 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1637 | $3.74 | 389,748.0000 | 169,521,849 | 0.42% | 0.00% |
| July 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 18276 | $3.68 | 371,472.0000 | 169,521,849 | 4.69% | 0.01% |
| April 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1644 | $3.17 | 404,328.0000 | 169,521,849 | 0.40% | 0.00% |
| April 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 12943 | $3.00 | 391,385.0000 | 169,521,849 | 3.20% | 0.01% |
| March 27, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 298 | $2.84 | 405,972.0000 | 169,521,849 | 0.07% | 0.00% |
| Jan. 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 20791 | $4.42 | 406,270.0000 | 0 | 4.87% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 33688 | $4.63 | 287,920.0000 | 0 | 10.47% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Common Stock | 139141 | $0.00 | 427,061.0000 | 0 | 48.33% | 0.00% |
| Jan. 10, 2025 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 299 | $4.38 | 321,608.0000 | 0 | 0.09% | 0.00% |
| Oct. 28, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1632 | $6.06 | 321,907.0000 | 0 | 0.50% | 0.00% |
| Sept. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 295 | $7.51 | 323,539.0000 | 0 | 0.09% | 0.00% |
| July 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1638 | $8.85 | 323,834.0000 | 0 | 0.50% | 0.00% |
| June 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 295 | $6.26 | 325,472.0000 | 0 | 0.09% | 0.00% |
| April 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1623 | $6.38 | 325,767.0000 | 0 | 0.50% | 0.00% |
| March 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 348 | $7.70 | 327,390.0000 | 0 | 0.11% | 0.00% |
| Jan. 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1929 | $9.64 | 327,738.0000 | 0 | 0.59% | 0.00% |
| Jan. 16, 2024 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Common Stock | 200000 | $0.00 | 329,667.0000 | 0 | 154.24% | 0.00% |
| Dec. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 294 | $11.51 | 129,667.0000 | 0 | 0.23% | 0.00% |
| Oct. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1632 | $6.03 | 129,961.0000 | 0 | 1.24% | 0.00% |
| Sept. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 294 | $8.38 | 131,593.0000 | 0 | 0.22% | 0.00% |
| July 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1628 | $11.80 | 131,887.0000 | 0 | 1.22% | 0.00% |
| June 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 294 | $12.12 | 133,515.0000 | 0 | 0.22% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 1936 | $11.16 | 133,809.0000 | 0 | 1.43% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 863 | $11.16 | 134,882.0000 | 0 | 0.64% | 0.00% |
| March 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 347 | $15.36 | 135,745.0000 | 0 | 0.25% | 0.00% |
| Jan. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 864 | $21.56 | 136,092.0000 | 0 | 0.63% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Stock Option (Right to Buy) | 73220 | $0.00 | 73,220.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Stock Option (Right to Buy) | 97630 | $0.00 | 97,630.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | A | Common Stock | 85425 | $0.00 | 136,956.0000 | 0 | 165.77% | 0.00% |
| Jan. 12, 2023 | Relay Therapeutics, Inc. | $RLAY | Adams Brian | Chief Legal Officer | S | Common Stock | 9994 | $20.00 | 51,531.0000 | 0 | 16.24% | 0.00% |